 |
|
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chang, Chao-Yung Wang, Chun-Yen Lin, Chung-Lieh Hung, Cheng-Yuan Peng, Ming-Lung Yu, Ting-Hsing Chao, Jee-Fu Huang, Yi-Hsiang Huang, Chi-Yi Chen, Chern-En Chiang, Han-Chieh Lin, Yi-Heng Li, Tsung-Hsien Lin, Jia-Horng Kao, Tzung-Dau Wang, Ping-Yen Liu, Yen-Wen Wu, Chun-Jen Liu
Clin Mol Hepatol. 2024;30(1):16-36. Published online 2023 Oct 4 DOI: https://doi.org/10.3350/cmh.2023.0315
|
|
Citations to this article as recorded by
 Metabolic dysfunction‐associated steatotic liver disease is associated with increased risks of heart failure
Kai‐Chun Chang, Tung‐Hung Su, Cho‐Kai Wu, Shang‐Chin Huang, Tai‐Chung Tseng, Chun‐Ming Hong, Shih‐Jer Hsu, Chen‐Hua Liu, Hung‐Chih Yang, Chun‐Jen Liu, Jia‐Horng Kao
European Journal of Heart Failure.2025;[Epub] CrossRef Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
Pin-Nan Cheng, Ming-Lung Yu
Clinical and Molecular Hepatology.2024; 30(2): 144. CrossRef MAFLD: from a disease framework to patient care
Mohammed Eslam, Jacob George
Hepatology International.2024; 18(S2): 823. CrossRef Effect of metabolic dysfunction on the risk of liver-related events in patients cured of hepatitis C virus
Wei-Fan Hsu
American Journal of Cancer Research.2024; 14(4): 1914. CrossRef The unfolded features on the synchronized fashion of gut microbiota and Drynaria rhizome against obesity via integrated pharmacology
Ki-Kwang Oh, Sang-Jun Yoon, Seol Hee Song, Jeong Ha Park, Jeong Su Kim, Min Ju Kim, Dong Joon Kim, Ki-Tae Suk
Food Chemistry.2024; 460: 140616. CrossRef High sensitivity troponins and mortality in the population with metabolic dysfunction-associated steatotic liver disease
Jingjing Hu, Yuteng Du, Yidan Zhou, Huiying Wang
Scientific Reports.2024;[Epub] CrossRef A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
Journal of Hepatology.2024;[Epub] CrossRef MASLD: an emerging factor in the pathophysiology and clinical management of ICC
Zong-Long Li, Jia-Lu Chen, Yue Tang, De-Long Qin, Zhao-Hui Tang
Hepatoma Research.2024;[Epub] CrossRef Reply to: “A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B: Is cirrhosis driving the performance?”
Moon Haeng Hur, Jeong-Hoon Lee
Journal of Hepatology.2024;[Epub] CrossRef Metabolic dysfunction-associated fatty liver disease: bridging cardiology and hepatology
Xiao-Dong Zhou, Giovanni Targher, Christopher D. Byrne, Michael D. Shapiro, Li-Li Chen, Ming-Hua Zheng
Cardiology Plus.2024; 9(4): 275. CrossRef
|